(lp0
S'Did Navidea Biopharmaceuticals Inc  Create Value For Shareholders Over ... Simply Wall St - Mar 21, 2017 With a ROE of 23.7%, Navidea Biopharmaceuticals Inc  could hardly match the performance of its industry, which averaged a ROE of 27.45%.$0.00 EPS Expected for Navidea Biopharmaceuticals ; Energizer Holdings ... - Herald KSThis Weeks Target Prices For Navidea Biopharmaceuticals, Inc.  - NewsDen'
p1
aS'NAVIDEA BIOPHARMACEUTICALS, INC.  Files An 8-K Departure of ... Market Exclusive - Mar 13, 2017 About NAVIDEA BIOPHARMACEUTICALS, INC.  Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics.Navidea Biopharmaceuticals, Inc.  Broker Price Targets For The Coming Week - Fiscal Standard'
p2
aS'Navidea Biopharmaceuticals, Inc : A Detailed Look at its ... Post Analyst - 16 hours ago Navidea Biopharmaceuticals, Inc  reached 150% versus a 1-year low price of $0.26. The stock was last seen 4.84% higher, reaching at $0.65 on Mar. 21, 2017.'
p3
aS'Navidea Biopharmaceuticals, Inc  Analyst Opinion And Outlook Post Analyst - 4 minutes ago Navidea Biopharmaceuticals, Inc  traded at an unexpectedly low level on Mar. 22, 2017 when the stock experienced a -7.71 loss to a closing price of $0.6.'
p4
aS'Navidea Biopharmaceuticals: Short-Term Pain Or Short-Term Gain? Seeking Alpha - Oct 10, 2016 Navidea  has recently been embroiled in a trench war of litigation with its loan instrument Capital Royalty Group , which starting in the first part of 2016.'
p5
aS'Stock Update: Technicals in View for Navidea Biopharmaceuticals Inc  Rives Journal - Mar 21, 2017 Navidea Biopharmaceuticals Inc  has a 14-day Commodity Channel Index  of -55.51. The CCI was designed to typically remain within the reading of -100 to +100.'
p6
aS"What We Expect Going Forward From Navidea Biopharmaceuticals Inc  Insider Financial - Oct 13, 2016 We've followed Navidea Biopharmaceuticals Inc  pretty closely over the last year or so. The company is embroiled in litigation, the outcome of which essentially could decide its future as a drugmaker, and this has weighed heavily on its&nbsp;..."
p7
aS"Navidea Biopharmaceuticals Enters into Letter of Intent with Cardinal Health ... Yahoo Finance - Sep 6, 2016 Navidea Biopharmaceuticals, Inc.  today announced that it has executed a Letter of Intent  with Cardinal Health, Inc.  for the sale of all rights, title and interest to Navidea's Lymphoseek product for all FDA-approved ...Navidea Biopharmaceuticals Inc  Navidea Biopharmaceuticals  Stock: Continuing Up | Can It Hold Onto Gains? - CNA Finance "
p8
aS'NAVIDEA BIOPHARMACEUTICALS, INC.  Files An 8-K Entry into a ... Market Exclusive - Mar 9, 2017 Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics.Investors Attention Alert: Navidea Biopharmaceuticals, Inc.  - Is storiesWhy to Keeping Eye on Navidea Biopharmaceuticals, Inc , Atwood Oceanics ... - StockNewsJournal'
p9
aS'NAVIDEA BIOPHARMACEUTICALS, INC.  Files An 8-K Submission of ... Market Exclusive - Mar 2, 2017 About NAVIDEA BIOPHARMACEUTICALS, INC.  Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics.'
p10
a.